| ViiV Healthcare GmbH - Rukobia 600 mg, Retardtabletten |
| 67854 | | 01 | | Rukobia 600 mg | | Retardtabletten | | J05AX29 | | Fostemsavir | | 28.09.2021 | | |
|
| Composition |
| fostemsavirum 600 mg ut fostemsavirum trometamolum, hydroxypropylcellulosum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, poly(alcohol vinylicus) E 171 macrogolum 3350 talcum E 172 (flavum) E 172 (rubrum), pro compresso obducto. |
| Packungsbestandteile |
| Comprimés retards | | | | Principe actif | Concentr. |
|---|
| Fostemsavirum | 600 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| (Rubrum) | | | Hydroxypropylcellulosum | | | Hypromellosum | | | Macrogolum 3350 Talcum e 172 (Flavum) E | 172 | | Magnesii Stearas | | | Poly(Alcohol Vinylicus) E | 171 | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 60 | DDP | DDP | A | | Non |
|
